We are live on ! Find out more
AMAM

Ambrx Biopharma Inc

Delisted

AMAM was delisted on the 6th of March, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$50.3M +$1.61M +89,285 +2%
CAM
2
Cormorant Asset Management
Massachusetts
$33.1M
FI
3
Fosun International
China
$26.1M
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$24.7M
AG
5
Artal Group
Luxembourg
$11.5M
BlackRock
6
BlackRock
New York
$11.1M -$548K -30,455 -4%
OCA
7
Octagon Capital Advisors
New York
$4.72M -$1.8M -100,000 -22%
Millennium Management
8
Millennium Management
New York
$1.91M -$47.9K -2,661 -2%
Norges Bank
9
Norges Bank
Norway
$945K
CCM
10
CAAS Capital Management
New York
$540K
Tudor Investment Corp
11
Tudor Investment Corp
Connecticut
$272K -$717K -39,857 -66%
GCM
12
Ghisallo Capital Management
Massachusetts
$203K -$450K -25,000 -63%
Morgan Stanley
13
Morgan Stanley
New York
$38K +$50.4K +2,800 New
MIFH
14
Migdal Insurance & Financial Holdings
Israel
$3K +$3.6K +200 New
Bank of America
15
Bank of America
North Carolina
$1K -$162 -9 -8%
SCM
16
Suvretta Capital Management
New York
-$22.9M -1,169,529 Closed
MIM
17
Monashee Investment Management
Massachusetts
-$2.16M -110,000 Closed
AllianceBernstein
18
AllianceBernstein
Tennessee
-$1.37M -70,000 Closed
MWNA
19
Marshall Wace North America
New York
-$640K -32,648 Closed
PHP
20
Parkman Healthcare Partners
Connecticut
-$294K -15,000 Closed
BFM
21
Boothbay Fund Management
New York
-$263K -13,422 Closed
PCM
22
Pinz Capital Management
New York
-$20K -1,000 Closed